ARTICLE
Auteur(s) : Tsuyoshi MITSUISHI tmitsu@nms.ac.jp, Seiji KAWANA
Department of Dermatology, Nippon Medical School, 1-1-5 Sendagi,
Bunkyou-ku, Tokyo, 113-8603, Japan
A 61-year-old female was referred to our hospital for evaluation
of a 6-month history of a solitary nodule on the nose. She did not
have any notable medical history. On clinical examination, a hard,
elastic, reddish nodule with a rough surface, 7 × 6 mm in diameter,
was observed on the nose (figure 1A).
The nodule was surgically removed under local anesthesia.
Microscopic examination revealed many well-differentiated tubular
structures, without connection to the follicular infundibulum,
located in the dermis (figure 1B).
The epidermis, with slight acanthosis, was almost intact and was
not attached to the tumor masses. In the dermis, each irregularly
shaped tubular structure was lined by 2 or more layers of cells,
with the inner layer formed by cuboidal cells and outer layer
formed by columnar cells. The cuboidal cells of the inner layer in
the tubular structures showed decapitation secretion. The cuboidal
and columnar cells showed absence of polymorphism, mitotic figures,
and irregularly shaped nuclei. Cellular fragments and eosinophilic
debris were observed in the tubular structure. The stroma of the
tumor consisted of numerous fibroblasts (figure 1C).
Immunohistochemical studies were performed on formalin-fixed,
paraffin embedded tissue, using carcinoembryonic antigen (CEA),
epithelial membrane antigen (EMA), cytokeratin (CK) 7, CAM 5.2,
p63, smooth muscle antigen (SMA), Ki-67 (MIB1), androgen receptor,
and gross cystic disease fluid protein (GCDFP)-15 antibodies. Among
them, EMA, and CEA were predominantly stained in the inner surface
of the tubular structure. SMA was slightly stained in the outer
surface of the tubular structure. CK 7 and CAM 5.2 were stained in
the numerous cells which consisted of the tubular structures
(figure
1D). The GCDFP-15 showed focal diffuse cytoplasmic
staining in most of the cells of the tubular structures (figure
1E). The proliferative index (MIB1) was
approximately 5% (figure 1F).
In contrast, the outer layer cells were positive for p63 (figure
1G). The androgen receptor was negative stained.
These findings demonstrate characteristic clinicopathological
features of tubular apocrine adenoma (TAA).
TAA is a rare sweat gland tumor that was first described by
Landry and Winkelmann in 1972 [1]. The tumor presents as a
well-defined nodule, mainly located on the scalp. Most lesions are
less than 2 cm in diameter. Histopathologically, TAA is
characterized by lobules of well differentiated tubular structures
found in the dermis. The cells forming the tubular structures show
apocrine differentiation with decapitation secretion [1]. As a
differential diagnosis, TAA and syringocystadenoma papilliferum
(SCAP) might represent a spectrum of single disease [2, 3].
Some authors have reported the coexistence of TAA and SCAP on the
scalp [2, 3]. These two types of tumors show similar clinical,
morphological, and immunohistochemical features and sometimes
overlap. They occasionally appear in a sebaceous nevus [3].
Histopathologically, TAA is mostly located within the deep dermis
and does not show cystically dilated invaginations or papillary
projections, in comparison to SCAP [1-3]. Thus, our case was
consistent with TAA. The tumor is usually located deep within the
dermis of the scalp region. Rarely, TAA has been described in other
locations such as the eyelid, chest, external auditory meatus,
cheek, and vulva [4]. To our best knowledge, the present case
represents the first description of TAA on the nose.
Deniake and Ackerman proposed that TTA in fact represents a
malignant skin tumor [5]. Some authors have reported that
aggressive clinical behavior may be observed [6]. Despite the lack
of cellular atypia, TTA is considered as a locally aggressive
malignancy [4, 6]. In our case, the cuboidal and columnar
cells consisted of tubular structures showing an absence of
polymorphism, mitotic figures, and atypical nuclei. Although
surgical excision was performed for this tumor, careful follow-up
should be recommended.
Disclosure
Financial support: none. Conflict of interest: none.
References
1 M Landry, R.K. Winkelmann An unusual tubular apocrine adenoma
Arch Dermatol 1972; 105: 869-879.
2 CK Lee, KT Jang, Y.S. Cho Tubular apocrine adenoma with
syringocystadenoma papilliferum arising from the external auditory
canal J Laryngol Otol 2005; 119: 1004-1006.
3 BK Ahn, YK Park, Y.C. Kim A case of tubular apocrine adenoma
with syringocystadenoma papilliferum arising in nevus sebaceus J
Dermatol 2004; 31: 508-510.
4 DE Demellawy, D Daya, S. Alowami Vulvar apocrine tubular
adenoma: an unusual location Int J Gynecol Pathol 2008; 27:
301-303.
5 Denianke K, Ackerman AB. Papillary eccrine adenoma is apocrine
papillary carcinoma. Available at: www.derm101.com.
6 JM Burket, A.S. Zelickson Tubular apocrine adenoma with
perineural invasion J Am Acad Dermatol 1984; 11:
639-642.
|